Table 4.
Genesb | RNA-seqc (LFM vs. CON) | Real-time PCRd (LFM vs. CON) | ||
---|---|---|---|---|
FC | P-value | FC | P-value | |
TNFRSF13C | 0.46 | 0.037 | 0.36 | 0.048 |
CXCL10 | 0.50 | 0.024 | 0.42 | 0.026 |
FABP1 | 8.77 | 0.002 | 8.36 | 0.034 |
LTA | 0.43 | 0.030 | 0.45 | 0.087 |
LYZ1 | 7.01 | 0.007 | 7.05 | 0.026 |
PIGR | 6.02 | 0.013 | 6.14 | 0.042 |
SLC5A8 | 2.02 | 0.022 | 2.69 | 0.035 |
TFF2 | 5.06 | 0.001 | 5.02 | 0.004 |
aData were presented as FC. The gene expressions were considered to be significantly altered when FC > 2 or < 0.5, P < 0.05
bTNFRSF13C: tumor necrosis factor receptor superfamily member 13C; CXCL10: C-X-C motif chemokine 10; FABP1: fatty acid binding protein 1; LTA: lymphotoxin alpha; LYZ1: lysozyme-like protein 1; PIGR: polymeric immunoglobulin receptor; SLC5A8: sodium-coupled monocarboxylate transporter; TFF2: trefoil factor 2
cResults based on RNA sequencing, n = 4
dResults based on real-time PCR, n = 6